Deverra Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Deverra Therapeutics's estimated annual revenue is currently $1.6M per year.
- Deverra Therapeutics's estimated revenue per employee is $77,500
- Deverra Therapeutics's total funding is $3M.
Employee Data
- Deverra Therapeutics has 20 Employees.
- Deverra Therapeutics grew their employee count by 25% last year.
Deverra Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and Chief Scientific Officer, EVP Research and Development | Reveal Email/Phone |
2 | President and Co-Founder | Reveal Email/Phone |
3 | Chief Regulatory & Compliance Officer | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | VP Manufacturing | Reveal Email/Phone |
6 | VP, Discovery and Translational Research | Reveal Email/Phone |
7 | Director, Clinical Operations | Reveal Email/Phone |
8 | Director Process Development | Reveal Email/Phone |
9 | Director, Cell Biology | Reveal Email/Phone |
10 | Office & Lab Manager | Reveal Email/Phone |
Deverra Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $3.3M | 43 | 10% | $101M | N/A |
#4 | $5.7M | 37 | 12% | N/A | N/A |
#5 | $7M | 45 | 41% | N/A | N/A |
#6 | $1.7M | 22 | -8% | N/A | N/A |
#7 | $3.9M | 50 | 4% | $10.1M | N/A |
#8 | $1.9M | 12 | -73% | N/A | N/A |
#9 | $29.3M | 151 | -17% | $148M | N/A |
#10 | $2M | 13 | 86% | N/A | N/A |
What Is Deverra Therapeutics?
Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.
keywords:N/A
$3M
Total Funding
20
Number of Employees
$1.6M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2M | 20 | N/A | N/A |
#2 | $2M | 20 | -17% | $95.3M |
#3 | $3.5M | 20 | -9% | N/A |
#4 | $3.4M | 20 | -5% | N/A |
#5 | $3.1M | 20 | -9% | N/A |